FindTrial
Sign In

Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

Analgesic Effect of Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section, A Prospective Randomized Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07033104
Enrollment
70
Registered
2025-06-24
Start date
2025-04-01
Completion date
2025-09-01
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transversalis Fascia Plane Block

Brief summary

Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

Interventions

OTHERus guided Transversalis fascia plane block

addition of calcitonin to pubivacaine

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* female pt ASA2 scheduled for cs under spinal anesthesia

Exclusion criteria

* patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

Design outcomes

Primary

MeasureTime frame
time to first rescue analgesia24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026